// App-Quantinova.ai

: Donor KIR3DL1/Receptor HLA-Bw4-80I Combination Reduce Acute Leukemia Relapse after Umbilical Cord Blood Transplantation without in Vitro T-Cell Depletion

Researchers

Presenter

  • Xinchen Fang

Principal Investigators

  • Zimin Sun

  • Huilan Liu

  • Lijun Xia

Medical Centers

  • The first affiliated hospital of China university of science and technology, Hefei, China

  • The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hematology, Hefei, China

  • the First Affiliated Hospital of University of Science and Technology of China, Hefei, China (People's Republic)

  • Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation Cardiovascular Bio. Rsch. Prog., Oklahoma City, OK

Locations

  • China

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Acute Leukemia

Biomarkers

  • Major Histocompatibility Complex, Class I, B

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved